...查看全文
美股滚雪球2022-07-22 14:13
CNS药物领域不错的公司:$Xenon制药(XENE)$ &$Intra-cellular(ITCI)$ 被收购的概率比较大。
$恒瑞医药(SH600276)$查看全文
chuminhua2021-10-05 10:48
10月4日,在Xenon Pharmaceuticals宣布在研药物XEN1101用于局灶性癫痫成年患者的辅助治疗的IIb期研究达到其主要疗效终点后,该公司的股票在周一翻了一番。
X-TOLE试验随机选抽取了325名局灶性癫痫的成年人,让他们接受三种每天一次的XEN1101剂量中的一种或安慰剂。结果显示,与安慰剂相比,这...查看全文
andrewmed2021-03-10 09:27
文章来源:“凯莱英药闻”微信公众号
2021年3月8日,Xenon Pharmaceuticals宣布与西奈山伊坎医学院合作,以推进一项研究者发起的概念验证性、双盲、随机、平行设计、安慰剂对照2期临床试验,评估XEN1101用于治疗重度抑郁症(MDD)和快感缺失。
为了测试XEN1101与安慰剂相比在MDD和重度快感...查看全文
智通财经APP获悉,10月4日(周一)美股盘初,截至北京时间22:02,专注于神经学的生物制药公司Xenon Pharmaceuticals(XENE.US)涨74.78%,报27.265美元。早前,该公司公布了2b期X-Tole临床试验的积极结果,该临床试验评估了XEN1101的临床有... 网页链接
$Xenon Pharmaceuticals Inc.(XENE)$ 8-K - Current report Filed: 2018-08-07 AccNo: 0001564590-18-020000 Size: 535 KBItem 1.01: Entry into a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement ...
$Xenon Pharmaceuticals Inc.(XENE)$ 8-K - Current report Filed: 2018-08-07 AccNo: 0001564590-18-020005 Size: 283 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Xenon Pharmaceuticals Inc.(XENE)$ 8-K - Current report Filed: 2018-08-07 AccNo: 0001564590-18-020000 Size: 535 KBItem 1.01: Entry into a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement ...
$Xenon Pharmaceuticals Inc.(XENE)$ 美东时间 2018-08-07 盘后 披露财报,预期EPS -0.49 网页链接
$Xenon Pharmaceuticals Inc.(XENE)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2018-07-13 AccNo: 0001615774-18-006468 Size: 65 KB 网页链接
$Xenon Pharmaceuticals Inc.(XENE)$ 8-K - Current report Filed: 2018-07-12 AccNo: 0001564590-18-016771 Size: 344 KBItem 1.01: Entry into a Material Definitive AgreementItem 1.02: Termination of a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Xenon Pharmaceuticals Inc.(XENE)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2018-07-12 AccNo: 0001564590-18-016768 Size: 877 KB 网页链接
$Xenon Pharmaceuticals Inc.(XENE)$ 8-K - Current report Filed: 2018-07-12 AccNo: 0001564590-18-016771 Size: 344 KBItem 1.01: Entry into a Material Definitive AgreementItem 1.02: Termination of a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Xenon Pharmaceuticals Inc.(XENE)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2018-07-12 AccNo: 0001564590-18-016768 Size: 877 KB 网页链接
$Xenon Pharmaceuticals Inc.(XENE)$ 8-K - Current report Filed: 2018-07-03 AccNo: 0001564590-18-016554 Size: 26 KBItem 8.01: Other Events 网页链接